- Report
- May 2024
- 137 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Clinical Trials
- March 2025
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- January 2021
Global
From €4247EUR$4,450USD£3,558GBP
- Drug Pipelines
- January 2024
- 80 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Drug Pipelines
- September 2021
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 72 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- November 2024
- 88 Pages
Global
From €3500EUR$3,929USD£3,035GBP

Adenosine is a drug used in the treatment of endocrine and metabolic disorders. It is a purine nucleoside that acts as a neuromodulator, regulating the activity of various neurotransmitters and hormones. Adenosine is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to treat certain types of heart failure, as well as to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms.
Adenosine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms, and is often prescribed in combination with other drugs.
Some companies in the Adenosine market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more